These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6084577)

  • 1. Ketanserin in chronic sympathetic dystrophy. An acute controlled trial.
    Bounameaux HM; Hellemans H; Verhaeghe R
    Clin Rheumatol; 1984 Dec; 3(4):556-7. PubMed ID: 6084577
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial.
    Hanna MH; Peat SJ
    Pain; 1989 Aug; 38(2):145-50. PubMed ID: 2780070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketanserin in acute superficial thrombophlebitis.
    de Roose J; Symoens J
    Lancet; 1982 Aug; 2(8295):440-1. PubMed ID: 6124830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and therapeutical findings on the use of benzopiperilon in Sudeck's syndrome].
    Bianchi C; Campacci R; Lupia V
    Minerva Ortop; 1968; 19(6):335-43. PubMed ID: 4191400
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketanserin (5 HT2-antagonist) in secondary Raynaud's phenomenon.
    Bounameaux HM; Hellemans H; Verhaeghe R; Dequeker J
    J Cardiovasc Pharmacol; 1984; 6(5):975-6. PubMed ID: 6209510
    [No Abstract]   [Full Text] [Related]  

  • 6. Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudication.
    Bounameaux H; Holditch T; Hellemans H; Berent A; Verhaeghe R
    Lancet; 1985 Dec; 2(8467):1268-71. PubMed ID: 2866336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with ketanserin, a serotonin (S2) antagonist, in longterm treatment of essential hypertension.
    Hedner T; Persson B; Berglund G
    Clin Exp Hypertens A; 1984; 6(3):743-51. PubMed ID: 6373066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
    Weiner CP; Socol ML; Vaisrub N
    Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
    Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G
    Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome.
    Prescott RW; Ratcliffe WA; Taylor PK
    Br Med J (Clin Res Ed); 1984 Sep; 289(6448):787-8. PubMed ID: 6089950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor.
    Seibold JR; Jageneau AH
    Arthritis Rheum; 1984 Feb; 27(2):139-46. PubMed ID: 6365102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra arterial ketanserin in peripheral vascular disease.
    Boas RA
    Angiology; 1986 Apr; 37(4):267-71. PubMed ID: 2940946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does ketanserin relieve frostbite?
    Vayssairat M; Priollet P; Hagege A; Housset E; Foray J
    Practitioner; 1986 May; 230(1415):406-8. PubMed ID: 2944086
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic use of ketanserin in a patient with carcinoid syndrome.
    Fischler M; Dentan M; Westerman MN; Vourc'h G; Freitag B
    Br J Anaesth; 1983 Sep; 55(9):920. PubMed ID: 6615683
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ketanserin in the treatment of ischemic disease of the lower extremities].
    Gerová Z; Brimichová E; Dzúrik R
    Cas Lek Cesk; 1985 Jul; 124(30):938-41. PubMed ID: 3161617
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of ketanserin in essential hypertension.
    Anderson A; Morgan T; Dumpys R
    Clin Exp Pharmacol Physiol; 1983; 10(3):331-3. PubMed ID: 6627748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies with ketanserin in hypertension.
    Waal-Manning HJ; Brown SA; Spears GF; Simpson FO
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S154-8. PubMed ID: 2412040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1 antagonistic and antiserotoninergic action during administration of ketanserin.
    Vermylen J; Fiocchi R; Fagard R; Lijnen P; Staessen J; Amery A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1551-2. PubMed ID: 6139140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.